(Q33373188)

26 July 2017

title

Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study (English)

1 reference

26 July 2017

main subject

phase II clinical trial

0 references

collaboration

1 reference

carcinoma of unknown primary

inferred from title

1 reference

1 reference

K B Pittman

1

1 reference

26 July 2017

I N Olver

2

1 reference

26 July 2017

B Koczwara

3

1 reference

26 July 2017

D Kotasek

4

1 reference

26 July 2017

W K Patterson

5

1 reference

26 July 2017

D M Keefe

6

1 reference

26 July 2017

C S Karapetis

7

1 reference

26 July 2017

F X Parnis

8

1 reference

26 July 2017

S Moldovan

9

1 reference

26 July 2017

S J Yeend

10

1 reference

26 July 2017

T J Price

11

1 reference

26 July 2017

Adelaide Cancer Trials and Education Collaborative (ACTEC)

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

31 October 2006

1 reference

British Journal of Cancer

26 July 2017

published in

1 reference

26 July 2017

volume

95

1 reference

26 July 2017

issue

10

1 reference

26 July 2017

page(s)

1309-1313

1 reference

Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360587

A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360587

Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360587

Empirical chemotherapy for adenocarcinoma of unknown primary tumor site

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360587

Reporting results of cancer treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360587

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360587

Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603440

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603440

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603440

Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603440

Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360587

Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study

31 October 2018

1 reference

12 December 2020

Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site

1 reference

12 December 2020

One-sample multiple testing procedure for phase II clinical trials

1 reference

12 December 2020

Gemcitabine and carboplatin in combination: phase I and phase II studies

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603440

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference